102 related articles for article (PubMed ID: 6490226)
1. Long term follow-up of mild chronic active hepatitis.
Surrenti C; Salvadori G; Casini A; Nieri S; Ricci OE; Ceccatelli P; Parenti S; Patussi V; Gentilini P
Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):435-7. PubMed ID: 6490226
[TBL] [Abstract][Full Text] [Related]
2. Long-term outcome after hepatitis B surface antigen seroclearance in patients with chronic hepatitis B.
Arase Y; Ikeda K; Suzuki F; Suzuki Y; Saitoh S; Kobayashi M; Akuta N; Someya T; Hosaka T; Sezaki H; Kobayashi M; Kumada H
Am J Med; 2006 Jan; 119(1):71.e9-16. PubMed ID: 16431195
[TBL] [Abstract][Full Text] [Related]
3. Development and prognosis of histologic cirrhosis in corticosteroid-treated hepatitis B surface antigen-negative chronic active hepatitis.
Davis GL; Czaja AJ; Ludwig J
Gastroenterology; 1984 Dec; 87(6):1222-7. PubMed ID: 6489694
[TBL] [Abstract][Full Text] [Related]
4. [Long-term prognosis of chronic B and C viral hepatitis].
Ohlen J; Liegl JM; Selmair H
Leber Magen Darm; 1995 Sep; 25(5):205-10. PubMed ID: 7500807
[TBL] [Abstract][Full Text] [Related]
5. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
[TBL] [Abstract][Full Text] [Related]
6. Lamivudine prophylaxis of liver allograft HBV reinfection in HBV related cirrhotic patients after liver transplantation.
Lu SC; Yan LN; Li B; Wen TF; Zhao JC; Cheng NS; Liu C; Liu J; Wang XB; Li XD; Qin S; Zhao LS; Lei BJ; Zhang XH
Hepatobiliary Pancreat Dis Int; 2004 Feb; 3(1):26-32. PubMed ID: 14969833
[TBL] [Abstract][Full Text] [Related]
7. Pathogenic role of hepatitis B virus in hepatitis B surface antigen-negative decompensated cirrhosis.
Chung HT; Lai CL; Lok AS
Hepatology; 1995 Jul; 22(1):25-9. PubMed ID: 7601418
[TBL] [Abstract][Full Text] [Related]
8. [Immunosuppressive therapy in patients with HBeAg-positive chronic active hepatitis B?].
Maier KP; Lepiorz H; Berthold H; Gerok W
Leber Magen Darm; 1982 Aug; 12(4):150-3. PubMed ID: 7132529
[TBL] [Abstract][Full Text] [Related]
9. [Clinico-prognostic significance of partial seroconversion in chronic viral hepatitis B follow-up. Wartenbert Study (1974-1994), II].
Ohlen I; Liegl JM; Selmair H
Leber Magen Darm; 1995 Dec; 25(6):259-62. PubMed ID: 8577215
[TBL] [Abstract][Full Text] [Related]
10. A 13-year longitudinal study of the impact of double mutations in the core promoter region of hepatitis B virus on HBeAg seroconversion and disease progression in patients with genotype C chronic active hepatitis.
Jang JW; Lee YC; Kim MS; Lee SY; Bae SH; Choi JY; Yoon SK
J Viral Hepat; 2007 Mar; 14(3):169-75. PubMed ID: 17305882
[TBL] [Abstract][Full Text] [Related]
11. Chronic active hepatitis in Italy: a multicentric study on clinical and laboratory data of 1154 cases. A report from the study group for CAH of the Italian Association for the Study of the Liver.
Hepatogastroenterology; 1983 Aug; 30(4):126-30. PubMed ID: 6629302
[TBL] [Abstract][Full Text] [Related]
12. Impact of hepatitis B and C virus infection on the outcome of kidney transplantation in Chinese patients.
Huo TI; Yang WC; Wu JC; King KL; Loong CC; Lin CY; Lui WY; Chang FY; Lee SD
Zhonghua Yi Xue Za Zhi (Taipei); 2000 Feb; 63(2):93-100. PubMed ID: 10677918
[TBL] [Abstract][Full Text] [Related]
13. Circulating immune complexes in chronic hepatitis as related to the presence of HBsAg.
Radu D; Dumitraşcu D; Părău N; Urcan S; Stanciu L; Tăpălagă D; Ban A; Dumitraşcu D; Rusu C
Med Interne; 1984; 22(1):61-5. PubMed ID: 6710050
[TBL] [Abstract][Full Text] [Related]
14. Long-term clinical and virological outcome after liver transplantation for cirrhosis caused by chronic delta hepatitis.
Samuel D; Zignego AL; Reynes M; Feray C; Arulnaden JL; David MF; Gigou M; Bismuth A; Mathieu D; Gentilini P
Hepatology; 1995 Feb; 21(2):333-9. PubMed ID: 7843702
[TBL] [Abstract][Full Text] [Related]
15. Sero-clearance of hepatitis B surface antigen in chronic carriers does not necessarily imply a good prognosis.
Huo TI; Wu JC; Lee PC; Chau GY; Lui WY; Tsay SH; Ting LT; Chang FY; Lee SD
Hepatology; 1998 Jul; 28(1):231-6. PubMed ID: 9657117
[TBL] [Abstract][Full Text] [Related]
16. [Is there a relationship between the presence of autoantibodies or mixed cryoglobulinemia and the clinical and histological characteristics of chronic viral hepatitis C?].
Rolachon A; Pasquier D; Girard M; Arvieux J; Bichard P; Bensa JC; Zarski JP
Gastroenterol Clin Biol; 1994; 18(3):251-6. PubMed ID: 7926441
[TBL] [Abstract][Full Text] [Related]
17. Long-term outcome of hepatitis B e antigen-positive patients with compensated cirrhosis treated with interferon alfa. European Concerted Action on Viral Hepatitis (EUROHEP).
Fattovich G; Giustina G; Realdi G; Corrocher R; Schalm SW
Hepatology; 1997 Nov; 26(5):1338-42. PubMed ID: 9362381
[TBL] [Abstract][Full Text] [Related]
18. Prognosis for the patients with chronic hepatitis B.
Colić-Cvrlje V; Naumovski-Mihalić S; Prskalo M; Colić A; Cvjeticanin B; Sabarić B
Coll Antropol; 2000 Jun; 24(1):211-6. PubMed ID: 10895548
[TBL] [Abstract][Full Text] [Related]
19. Methyl-prednisolone treatment of serum HBsAg negative chronic active hepatitis occurring in transfusion-dependent thalassemia major.
De Virgiliis S; Argiolu F; Rais M; Cossu P; Toccafondi C; Sanna G; Cornacchia G; Nucaro A; Bertolino F; Ferreli A
Helv Paediatr Acta; 1983 Aug; 38(3):255-65. PubMed ID: 6618892
[TBL] [Abstract][Full Text] [Related]
20. Long-term follow-up of hepatitis B virus carriers with normal transaminases levels.
Koçak N; Ozen H; Yüce A; Gürakan F
Turk J Pediatr; 1998; 40(3):365-72. PubMed ID: 9763900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
